Story at a glanceWith the U.S. hovering closer to 200,000 coronavirus fatalities, the pressure to develop an effective vaccine grows. But health officials continue to say a widespread vaccine will not be available until mid-2021.“A vaccine that would be widely available in hundreds and millions of doses would not likely happen until mid-2021. That is a fact,” he said.The distribution of just a few million doses of the vaccine, however, could still lead to a marked improvement, Giroir noted. “From my perspective, even a few million doses early in November or December, if we have 5 or 10...…Story at a glanceWith the U.S. hovering closer to 200,000 coronavirus fatalities, the pressure to develop an effective vaccine grows. But health officials continue to say a widespread vaccine will not be available until mid-2021.“A vaccine that would be widely available in hundreds and millions of doses would not likely happen until mid-2021. That is a fact,” he said.The distribution of just a few million doses of the vaccine, however, could still lead to a marked improvement, Giroir noted. “From my perspective, even a few million doses early in November or December, if we have 5 or 10...WW…